Email the author Proportions of Hypertension in Stable COPD Patients at the National Respiratory Center Persahabatan Hospital
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. Most of these deaths are related to cardiovascular disease. This is due to systemic inflammation that causes increased vascular stiffness and hypertension. These comorbidities lead to poor quality of life, low exercise tolerance, and an increased risk of hospitalization. This study aims to report the proportion of hypertension among stable COPD patients in the Indonesian population.
Methods: This cross-sectional study was conducted at the National Respiratory Center Persahabatan Hospital between February and March 2023. Stable COPD patients admitted to the Asthma and COPD Polyclinic who met the criteria were enrolled. Clinical information, vital signs, spirometry results, and DLCO measurements were collected.
Results: There were 84 subjects participating in this study. The result of this study shows a 60.7% proportion of hypertension in stable COPD patients. Hypertension has a significant correlation with pulmonary functional values (P=0.021), severity degree of clinical COPD (P=0.004), Brinkman index (P=0.008), and age (P=0.0001). However, hypertension association with COPD duration (P=0.505) and DLCO (P=0.122) were not significant.
Conclusion: The hypertension proportion in stable COPD Indonesian patients is 60.7%. Hypertension shows a significant association with pulmonary function values, severity degree of clinical COPD, Brinkman index, and age.
Keywords
Full Text:
PDFReferences
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for The Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report). Global Initiative for Chronic Obstructive Lung Disease, Inc.; 2023.
Valipour A, Aisanov Z, Avdeev S, Koblizek V, Kocan I, Kopitovic I, et al. Recommendations for COPD management in Central and Eastern Europe. Expert Rev Respir Med. 2022;16(2):221–34.
Aisanov Z, Khaltaev N. Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients. J Thorac Dis. 2020;12(5):2791–802.
Rabe KF, Hurst JR, Suissa S. Cardiovascular disease and COPD: dangerous liaisons? European Respiratory Review. 2018;27(149):180057.
. Greulich T, Weist BJD, Koczulla AR, Janciauskiene S, Klemmer A, Lux W, et al. Prevalence of comorbidities in COPD patients by disease severity in a German population. Respir Med. 2017;132:132–8.
Ratnawati R, Kolewora YM, Yunus F, Susanto AD, Samoedro E. Prevalence of COPD Outpatient Based on COPD Diagnostic Questionnaire and Spirometry in Persahabatan General Hospital in Jakarta. In: American Thoracic Society 2019 International Conference. American Thoracic Society; 2019. p. A1608–A1608.
Mahishale V, Angadi N, Metgudmath V, Eti A, Lolly M, Khan S. Prevalence and impact of diabetes, hypertension, and cardiovascular diseases in chronic obstructive pulmonary diseases: A hospital-based cross-section study. J Transl Int Med. 2015;3(4):155–60.
Van Remoortel H, Hornikx M, Langer D, Burtin C, Everaerts S, Verhamme P, et al. Risk Factors and Comorbidities in the Preclinical Stages of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2014;189(1):30–8.
PDPI. PPOK (penyakit paru obstruktif kronik) diagnosis dan penatalaksanaan. Jakarta: PDPI; 2016.
Casanova C, Gonzalez-Dávila E, Martínez-Gonzalez C, Cosio BG, Fuster A, Feu N, et al. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD. Chest. 2021;160(2):481–90.
Hyatt RE, Scanlon PD, Nakamura M. Interpretation of Pulmonary Function Tests: A Practical Guide (Fourth edition). China: Wolters Kluwer; 2014. 35–41 p.
Brouwers S, Sudano I, Kokubo Y, Sulaica EM. Arterial hypertension. The Lancet. 2021;398(10296):249–61.
Singh DR. Prevalence of Hypertension in Patients with Chronic Obstructive Pulmonary Disease Attending Respiratory Medicine OPD. Int J Med Sci Clin Invent. 2017;4(12):3346–8.
Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–58.
Kementerian Kesehatan RI. Laporan Nasional Riskesdas 2018. Laporan Nasional Riskesdas 2018. Jakarta; 2018.
Chen J, Yin Y, Zhang Y, Lin X, Chen T, Yang Z, et al. Chronic Obstructive Pulmonary Disease Prevalence and Associated Risk Factors in Adults Aged 40 Years and Older in Southeast China: A Cross-Sectional Study During 2019–2020. Int J Chron Obstruct Pulmon Dis. 2022;17:2317–28.
Zhao Y, Fang L, Wang Z, Fan J, Cong S, Wu J. Prevalence and Associated Factors of COPD among Hypertensive Patients aged 40 Years or Older in China, 2014 -15. Research Square. 2022.
MacNee W. Is Chronic Obstructive Pulmonary Disease an Accelerated Aging Disease? Ann Am Thorac Soc. 2016;13(Supplement_5):S429–37.
Hussain MA, Mamun A Al, Reid C, Huxley RR. Prevalence, Awareness, Treatment and Control of Hypertension in Indonesian Adults Aged ≥40 Years: Findings from the Indonesia Family Life Survey (IFLS). PLoS One. 2016;11(8):e0160922.
Kharbanda S, Anand R. Health-related quality of life in patients with chronic obstructive pulmonary disease: A hospital-based study. Indian Journal of Medical Research. 2021;153(4):459–64.
Ariawan W, Yunus F, Damayanti T, Nurwidya F. Rate of forced expiratory volume in one second and forced expiratory volume in one second/forced vital capacity decline among Indonesian patients with chronic obstructive pulmonary disease after a year of treatment. Int J Appl Basic Med Res. 2019;9(2):95–9.
Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y, et al. Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study. Respir Res. 2022;23(1):106.
Cui Y, Dai Z, Luo L, Chen P, Chen Y. Classification and treatment of chronic obstructive pulmonary disease outpatients in China according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: comparison with GOLD 2014. J Thorac Dis. 2019;11(4):1303–15.
Perhimpunan Dokter Hipertensi Indonesia. Konsensus penatalaksanaan hipertensi 2021: update konsensus PERHI 2019. Jakarta: Perhimpunan Dokter Hipertensi Indonesia; 2021. 1–6 p.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–57.
Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Pedoman tatalaksana hipertensi pada penyakit kardiovaskular. Jakarta: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia; 2015. 1–2 p.
dos Santos NC, Miravitlles M, Camelier AA, Almeida VDC de, Maciel RRBT, Camelier FWR. Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review. Tuberc Respir Dis (Seoul). 2022;85(3):205–20.
Kim SH, Park JH, Lee JK, Heo EY, Kim DK, Chung HS. Chronic obstructive pulmonary disease is independently associated with hypertension in men. Medicine. 2017;96(19):e6826.
Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. European Respiratory Journal. 2008;32(4):962–9.
Mills KT, Stefanescu A, He J. The Global Epidemiology of Hypertension. Nat Rev Nephrol. 2020;16(4):223–37.
Raherison C, Ouaalaya EH, Bernady A, Casteigt J, Nocent-Eijnani C, Falque L, et al. Comorbidities and COPD severity in a clinic-based cohort. BMC Pulm Med. 2018;18(1):117.
García Rodríguez LA, Wallander MA, Tolosa LB, Johansson S. Chronic Obstructive Pulmonary Disease in UK Primary Care: Incidence and Risk Factors. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2009;6(5):369–79.
Ismail E, Yunus F, Damayanti T. Correlation between Measurement of Lung Diffusion Capacity Using Single Breath Methods (DLCO-SB) and COPD Group in Persahabatan Hospital Jakarta. Jurnal Respirologi Indonesia. 2021;41(4):260–71.
Hanif MA, Wiyono WH, Ratnawati, Prihartono J, Antariksa B, Zaini J. Skor gabungan curb 65 dan rasio kapasitas inspirasi kapasitas paru total sebagai prediktor mortalitas dan eksaserbasi pada PPOK dalam satu tahun [Tesis]. [Jakarta]: Universitas Indonesia; 2013.
Boyer L, Bastuji-Garin S, Chouaid C, Housset B, Le Corvoisier P, Derumeaux G, et al. Are Systemic Manifestations Ascribable to COPD in Smokers? A Structural Equation Modeling Approach. Sci Rep. 2018;8(1):8569.
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for The Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2022 Report). Global Initiative for Chronic Obstructive Lung Disease; 2022.
Morrison NJ, Abboud RT, Ramadan F, Miller RR, Gibson NN, Evans KG, et al. Comparison of Single Breath Carbon Monoxide Diffusing Capacity and Pressure-Volume Curves in Detecting Emphysema. American Review of Respiratory Disease. 1989;139(5):1179–87.
Sin DD, Wu L, Man SFP. The Relationship Between Reduced Lung Function and Cardiovascular Mortality. Chest. 2005;127(6):1952–9.
Engström G, Wollmer P, Hedblad B, Juul-Möller S, Valind S, Janzon L. Occurrence and Prognostic Significance of Ventricular Arrhythmia Is Related to Pulmonary Function. Circulation. 2001;103(25):3086–91.
Sin DD, Man SFP. Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases? Circulation. 2003;107(11):1514–9.
Tockman MS, Pearson JD, Fleg JL, Metter EJ, Kao SY, Rampal KG, et al. Rapid decline in FEV1. A new risk factor for coronary heart disease mortality. Am J Respir Crit Care Med. 1995;151(2 Pt 1):390–8.
DOI: https://doi.org/10.36497/jri.v44i3.774
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Luhur Dewantoro, Wiwien Heru Wiyono, Faisal Yunus, Heidy Agustin, Triya Damayanti, Budhi Antariksa, Fanny Fachrucha, Erlang Samoedro, Mia Elhidsi
INDEXING & PARTNER
| Jurnal Respirologi Indonesia pISSN: 0853-7704 - eISSN: 2620-3162 Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia Phone: +62-21-2247-4845 Email: editor@jurnalrespirologi.org |  An official publication by the Indonesian Society of Respirology (ISR) |
 Creative Commons Attribution-ShareAlike 4.0 International License Statcounter |